Clinical Trial Update: A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating a vitamin B3 derivative for mitochondrial myopathy, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Myopathy

Drugs mentioned

• Vitamin B3 derivative

Snippet

Sponsor: Ralitza Gavrilova | Conditions: Mitochondrial Myopathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING